Procyon Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,628
Closed -$211K 527
2025
Q2
$211K Sell
2,628
-36,063
-93% -$2.78M 0.02% 441
2025
Q1
$3.11M Buy
38,691
+3,379
+10% +$281K 0.19% 116
2024
Q4
$2.89M Buy
35,312
+8,813
+33% +$733K 0.18% 116
2024
Q3
$2.19M Buy
26,499
+836
+3% +$62.5K 0.15% 151
2024
Q2
$1.8M Buy
25,663
+2,236
+10% +$160K 0.13% 163
2024
Q1
$1.74M Buy
23,427
+1,842
+9% +$128K 0.13% 166
2023
Q4
$1.43M Buy
21,585
+1,182
+6% +$74K 0.12% 176
2023
Q3
$1.28M Buy
20,403
+11,515
+130% +$717K 0.13% 170
2023
Q2
$502K Buy
+8,888
New +$493K 0.06% 270
2020
Q3
Sell
-673
Closed -$25K 702
2020
Q2
$25K Hold
673
0.01% 501
2020
Q1
$21K Sell
673
-79
-11% -$3.5K 0.01% 473
2019
Q4
$38K Buy
+752
New +$36.3K 0.02% 384

Other funds holding MET

Procyon Advisors's MET Position: Q3 2025 in Review

Procyon Advisors sold out of MetLife (MET) in Q3 2025, closing a stake of 2,628 shares — an estimated $211K sold.

Procyon Advisors first reported a position in MET in Q4 2019 and held it in 12 quarters. The position peaked at $3.11M in Q1 2025. 1,368 funds tracked by Wall St. Rank hold MET as of Q3 2025.

  • Procyon Advisors reported no remaining MetLife position as of Q3 2025 after selling out during the quarter.
  • Procyon Advisors sold 2,628 MetLife shares in Q3 2025, an estimated $211K.
  • Procyon Advisors first reported a position in MetLife in Q4 2019 and held it in 12 quarters.
  • Procyon Advisors's MetLife position peaked at $3.11M in Q1 2025.
  • 1,368 funds tracked by Wall St. Rank held MetLife as of Q3 2025.

Based on Procyon Advisors's 13F filing for Q3 2025, filed 28 Oct 2025.